Immunology and cutaneous malignant melanoma.
作者信息
Sober A J
出版信息
Int J Dermatol. 1976 Jan-Feb;15(1):1-18. doi: 10.1111/j.1365-4362.1976.tb05089.x.
Abstract
摘要
相似文献
1
Immunology and cutaneous malignant melanoma.免疫学与皮肤恶性黑色素瘤
Int J Dermatol. 1976 Jan-Feb;15(1):1-18. doi: 10.1111/j.1365-4362.1976.tb05089.x.
2
Immunology of human malignant melanoma.人类恶性黑色素瘤的免疫学
Ser Haematol. 1972;5(5):44-65.
3
Results of administering B.C.G. to patients with melanoma.给黑色素瘤患者接种卡介苗的结果。
Lancet. 1974 Nov 9;2(7889):1096-100. doi: 10.1016/s0140-6736(74)90867-8.
4
Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.人类恶性黑色素瘤的免疫学与免疫治疗：历史回顾与未来展望
Semin Oncol. 1975 Jun;2(2):155-74.
5
BCG in cancer therapy: theoretical bases of immunotherapy.卡介苗在癌症治疗中的应用：免疫疗法的理论基础。
Am J Nurs. 1979 Feb;79(2):310-4.
6
In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.卡介苗治疗恶性黑色素瘤的细胞介导免疫体外测定：初步报告。
Natl Cancer Inst Monogr. 1973 Dec;39:221-4.
7
[Immunological aspects of melanoma].[黑色素瘤的免疫学方面]
Lakartidningen. 1976 Feb 11;73(7):528-30.
8
The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma.恶性黑色素瘤患者中卡介苗介导的肿瘤消退的免疫和组织病理学变化。
Cancer. 1975 Mar;35(3):756-77. doi: 10.1002/1097-0142(197503)35:3<756::aid-cncr2820350331>3.0.co;2-z.
9
[Immunotherapy].[免疫疗法]
Acta Chir Belg. 1974 Mar;73(2):265-93.
Zotero 插件